Title : The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer.

Pub. Date : 2013 Sep

PMID : 23873478






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Radioimmunotherapy studies in p53-positive HCT116 tumor-bearing mice, receiving either radioimmunotherapy alone or in combination with cisplatin, showed significantly longer survival in mice receiving unlabeled cetuximab or cisplatin alone or in combination (all, P < 0.01). Cisplatin transformation related protein 53, pseudogene Mus musculus
2 Radioimmunotherapy studies in p53-positive HCT116 tumor-bearing mice, receiving either radioimmunotherapy alone or in combination with cisplatin, showed significantly longer survival in mice receiving unlabeled cetuximab or cisplatin alone or in combination (all, P < 0.01). Cisplatin transformation related protein 53, pseudogene Mus musculus
3 In contrast, the p53-negative tumor-bearing mice treated with radioimmunotherapy alone or combined with cisplatin showed no survival advantage, compared with control groups (all, P > 0.05). Cisplatin transformation related protein 53, pseudogene Mus musculus